AlphaCentric Advisors LLC

Other Low signal CIK 1913464
League rank
#827
in Other · #2836 overall
Long book
$100.1M
Q1 2026
Positions
252
Top-10 weight
20%
concentration
Last quarter
+12.7%
SPY +14.8%
Turnover
36%
of book per quarter

Strategy in plain words

auto-generated from filings

AlphaCentric Advisors LLC is an institutional manager, running a $100.1M US long book across 252 positions.

The portfolio is broadly diversified across 252 positions (top 10 only 20%). The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: GILEAD SCIENCES INC, INVESCO S&P 500 PURE VALUE E, ISHARES RUSSELL 1000 VALUE E, ASTRAZENECA PLC, VERTEX PHARMACEUTICALS INC.

Over the last 6 quarters its long book ran on average 0.5pp per quarter behind the S&P 500, beating the index in 3 of 6 quarters. Signal value of individual moves is limited — treat changes as weak evidence.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-2.9%
Q2 2024
+8.7%
Q3 2024
-0.4%
Q4 2024
-1.1%
Q4 2025
-1.5%
Q1 2026
+12.7%

Sector allocation

Healthcare
53%
Technology
13%
Financials
9%
Industrials
8%
Consumer discretionary
5%
Other
4%
Materials
3%
Real estate
2%

Long book by quarter

$165.8M
Q1 2024
$135.8M
Q2 2024
$134.5M
Q3 2024
$100.2M
Q4 2024
$100.3M
Q4 2025
$100.1M
Q1 2026

What does AlphaCentric Advisors own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
GILD GILEAD SCIENCES INCHealthcare20.3K$2.8M2.8%-6.9%
AZN ASTRAZENECA PLCHealthcare11.2K$2.2M2.2%New
VRTX VERTEX PHARMACEUTICALS INCHealthcare4.9K$2.2M2.2%+5.7%
EEFT EURONET WORLDWIDE INCFinancials27.9K$1.8M1.8%Held
IONS IONIS PHARMACEUTICALS INCHealthcare19.6K$1.5M1.5%+5.7%
INSM INSMED INCHealthcare8.9K$1.5M1.4%+16.9%
INCY INCYTE CORPHealthcare14.2K$1.3M1.3%+5.7%
ROIV ROIVANT SCIENCES LTDHealthcare47.7K$1.3M1.3%+5.7%
NBIX NEUROCRINE BIOSCIENCES INCHealthcare9.6K$1.3M1.3%+30.1%
AXR AMREP CORPReal estate44.5K$1.3M1.3%-31.5%
STXS STEREOTAXIS INCHealthcare600.0K$1.1M1.1%Held
AXSM AXSOME THERAPEUTICS INCHealthcare6.4K$1.1M1.1%+5.7%
AMPX AMPRIUS TECHNOLOGIES INCTechnology60.0K$1.0M1.0%+20.0%
APGE APOGEE THERAPEUTICS INCHealthcare11.4K$957K1.0%+5.7%
PTGX PROTAGONIST THERAPEUTICS INCHealthcare9.0K$953K1.0%+5.7%
BLDR BUILDERS FIRSTSOURCE INCConsumer discretionary10.0K$823K0.8%New
AMGN AMGEN INCHealthcare2.3K$819K0.8%+5.8%
INGM INGRAM MICRO HOLDING CORPConsumer discretionary35.0K$816K0.8%-15.9%
RYTM RHYTHM PHARMACEUTICALS INCHealthcare9.3K$809K0.8%+84.0%
ISRG INTUITIVE SURGICAL INCHealthcare1.8K$807K0.8%+16.7%
ABBV ABBVIE INCHealthcare3.5K$771K0.8%+19.0%
ROK ROCKWELL AUTOMATION INCOther2.0K$718K0.7%Held
BIIB BIOGEN INCHealthcare3.8K$703K0.7%+5.7%
PNNT PENNANTPARK INVESTMENT CORP155.9K$700K0.7%New
JAZZ JAZZ PHARMACEUTICALS PLCHealthcare3.6K$673K0.7%+5.7%
AVAV AEROVIRONMENT INCIndustrials3.6K$667K0.7%+45.8%
SYM SYMBOTIC INCIndustrials12.5K$665K0.7%Held
AEVA AEVA TECHNOLOGIES INCIndustrials50.0K$658K0.7%Held
LUNR INTUITIVE MACHINES INCTechnology35.0K$650K0.6%-30.0%
GMED GLOBUS MEDICAL INC - AHealthcare7.5K$646K0.6%-13.9%
SERV SERVE ROBOTICS INCIndustrials75.0K$633K0.6%Held
PDYN PALLADYNE AI CORPTechnology100.0K$607K0.6%Held
RCAT RED CAT HOLDINGS INCTechnology45.0K$589K0.6%New
CPRX CATALYST PHARMACEUTICALS INCHealthcare23.3K$577K0.6%+5.7%
ORKA ORUKA THERAPEUTICS INCHealthcare11.5K$564K0.6%+5.8%
KTOS KRATOS DEFENSE & SECURITYIndustrials8.0K$564K0.6%+6.7%
GPK GRAPHIC PACKAGING HOLDING COOther55.0K$547K0.5%Held
RR RICHTECH ROBOTICS INC-CL BIndustrials250.0K$523K0.5%Held
KDK KODIAK AI INCTechnology75.0K$521K0.5%Held
SOUN SOUNDHOUND AI INC-ATechnology75.0K$515K0.5%+20.0%
T AT&T INCCommunications17.6K$511K0.5%+53.5%
XMTR XOMETRY INC-AServices media12.5K$511K0.5%New
ONDS ONDAS INCTechnology55.0K$497K0.5%New
KRYS KRYSTAL BIOTECH INCHealthcare1.9K$495K0.5%+5.8%
EWTX EDGEWISE THERAPEUTICS INCHealthcare15.6K$492K0.5%+6.2%
MBOT MICROBOT MEDICAL INCHealthcare200.0K$482K0.5%Held
NUVL NUVALENT INC-AHealthcare4.7K$477K0.5%+5.7%
AGIO AGIOS PHARMACEUTICALS INCHealthcare14.0K$473K0.5%+6.3%
NAMS NEWAMSTERDAM PHARMA CO NVHealthcare14.7K$469K0.5%+6.7%
MANH MANHATTAN ASSOCIATES INCTechnology3.5K$466K0.5%New

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 7, 2026293$100.1M canonicalSEC ↗
Q4 202513F-HRFeb 12, 2026250$100.3M canonicalSEC ↗
Q4 202413F-HRJan 31, 2025212$100.2M canonicalSEC ↗
Q3 202413F-HROct 30, 2024231$134.5M canonicalSEC ↗
Q2 202413F-HRJul 25, 2024218$135.8M canonicalSEC ↗
Q1 202413F-HRApr 24, 2024228$165.8M canonicalSEC ↗